Science Corporation's Max Hodak Implants Vision Chip in First Stargardt Disease Patient
Max Hodak, CEO of Science Corporation, announced the successful implantation of the PRIMA vision restoration chip in the first patient with Stargardt disease. This hereditary condition progressively damages central vision, affecting approximately 150,000 people globally. The PRIMA project is part of...
